148 related articles for article (PubMed ID: 3510930)
1. Islet cell antibodies identify latent type I diabetes in patients aged 35-75 years at diagnosis.
Groop LC; Bottazzo GF; Doniach D
Diabetes; 1986 Feb; 35(2):237-41. PubMed ID: 3510930
[TBL] [Abstract][Full Text] [Related]
2. [Detection of antibodies against pancreatic islet cells in clinical practice].
Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L
Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715
[TBL] [Abstract][Full Text] [Related]
3. Beta-cell function in relation to islet cell antibodies during the first 3 yr after clinical diagnosis of diabetes in type II diabetic patients.
Gottsäter A; Landin-Olsson M; Fernlund P; Lernmark A; Sundkvist G
Diabetes Care; 1993 Jun; 16(6):902-10. PubMed ID: 8325204
[TBL] [Abstract][Full Text] [Related]
4. Correlation between residual beta-cell function and islet cell antibodies in newly diagnosed type I diabetes. Follow-up study.
Peig M; Gomis R; Ercilla G; Casamitjana R; Bottazzo GF; Pujol-Borrell R
Diabetes; 1989 Nov; 38(11):1396-401. PubMed ID: 2695374
[TBL] [Abstract][Full Text] [Related]
5. Organ-specific autoimmunity and HLA-DR antigens as markers for beta-cell destruction in patients with type II diabetes.
Groop L; Miettinen A; Groop PH; Meri S; Koskimies S; Bottazzo GF
Diabetes; 1988 Jan; 37(1):99-103. PubMed ID: 3275559
[TBL] [Abstract][Full Text] [Related]
6. Islet-cell antibodies in IDDM and NIDDM in a Japanese population.
Kobayashi T; Sawano S; Sugimoto T; Itoh T; Kosaka K; Tanaka T; Suwa S
Tohoku J Exp Med; 1983 Dec; 141 Suppl():271-4. PubMed ID: 6393435
[TBL] [Abstract][Full Text] [Related]
7. Islet cell and thyrogastric antibodies in 633 consecutive 15- to 34-yr-old patients in the diabetes incidence study in Sweden.
Landin-Olsson M; Karlsson FA; Lernmark A; Sundkvist G
Diabetes; 1992 Aug; 41(8):1022-7. PubMed ID: 1628762
[TBL] [Abstract][Full Text] [Related]
8. Islet cell antibodies and insulin autoantibodies in patients treated with oral hypoglycaemic agents.
Jennings AM; Spencer KM; Dean BM; Wilson RM; Bottazzo GF; Ward JD
Diabet Med; 1989 Jul; 6(5):434-9. PubMed ID: 2527682
[TBL] [Abstract][Full Text] [Related]
9. A 12-year prospective study of the relationship between islet antibodies and beta-cell function at and after the diagnosis in patients with adult-onset diabetes.
Borg H; Gottsäter A; Fernlund P; Sundkvist G
Diabetes; 2002 Jun; 51(6):1754-62. PubMed ID: 12031962
[TBL] [Abstract][Full Text] [Related]
10. GAD 65 antibody but not ICA positivity in adult-onset diabetic patients is associated with early progression to clinical insulin dependency.
Hatziagelaki E; Jaeger C; Maeser E; Bretzel RG; Federlin K
Acta Diabetol; 1996 Dec; 33(4):291-4. PubMed ID: 9033970
[TBL] [Abstract][Full Text] [Related]
11. Demonstration of islet cell antibodies in apparently non-insulin dependent diabetic patients; a marker for the later development of insulin dependency.
Katsura H; Itoh N; Hanafusa T; Kono N; Tarui S
Med J Osaka Univ; 1991 Mar; 40(1-4):67-71. PubMed ID: 1369659
[TBL] [Abstract][Full Text] [Related]
12. Correlation of islet cell antibodies and HLA-DR phenotypes with diabetes mellitus in adults.
Gleichmann H; Zörcher B; Greulich B; Gries FA; Henrichs HR; Betrams J; Kolb H
Diabetologia; 1984 Jul; 27 Suppl():90-2. PubMed ID: 6383926
[TBL] [Abstract][Full Text] [Related]
13. Immune abnormalities in diabetic patients not requiring insulin at diagnosis.
Di Mario U; Irvine WJ; Borsey DQ; Kyner JL; Weston J; Galfo C
Diabetologia; 1983 Nov; 25(5):392-5. PubMed ID: 6360778
[TBL] [Abstract][Full Text] [Related]
14. Relation between insulin antibody and complement-fixing islet cell antibody at clinical diagnosis of IDDM.
Karjalainen J; Knip M; Mustonen A; Ilonen J; Akerblom HK
Diabetes; 1986 May; 35(5):620-2. PubMed ID: 3514336
[TBL] [Abstract][Full Text] [Related]
15. Immunological heterogeneity in type I diabetes: presence of distinct autoantibody patterns in patients with acute onset and slowly progressive disease.
Seissler J; de Sonnaville JJ; Morgenthaler NG; Steinbrenner H; Glawe D; Khoo-Morgenthaler UY; Lan MS; Notkins AL; Heine RJ; Scherbaum WA
Diabetologia; 1998 Aug; 41(8):891-7. PubMed ID: 9726590
[TBL] [Abstract][Full Text] [Related]
16. Islet cell-associated autoantibodies in Ethiopians with diabetes mellitus.
Siraj ES; Gupta MK; Yifter H; Ahmed A; Kebede T; Reja A; Abdulkadir J
J Diabetes Complications; 2016 Aug; 30(6):1039-42. PubMed ID: 27220543
[TBL] [Abstract][Full Text] [Related]
17. Influence of age on the associations among insulin autoantibodies, islet cell antibodies, and HLA DAQ1*0301-DQB1*0302 in siblings of patients with type 1 (insulin-dependent) diabetes mellitus. Belgian Diabetes Registry.
Gorus FK; Vandewalle CL; Dorchy H; Van Crombrugge P; Schuit FC; Pipeleers DG
J Clin Endocrinol Metab; 1994 May; 78(5):1172-8. PubMed ID: 8175975
[TBL] [Abstract][Full Text] [Related]
18. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children.
Yamamoto AM; Deschamps I; Garchon HJ; Roussely H; Moreau N; Beaurain G; Robert JJ; Bach JF
J Autoimmun; 1998 Dec; 11(6):643-50. PubMed ID: 9878086
[TBL] [Abstract][Full Text] [Related]
19. Islet cell antibodies (ICA) identify autoimmunity in children with new onset diabetes mellitus negative for other islet cell antibodies.
Andersson C; Kolmodin M; Ivarsson SA; Carlsson A; Forsander G; Lindblad B; Ludvigsson J; Kockum I; Marcus C; Samuelsson U; Ortqvist E; Lernmark A; Elding Larsson H; Törn C;
Pediatr Diabetes; 2014 Aug; 15(5):336-44. PubMed ID: 24206368
[TBL] [Abstract][Full Text] [Related]
20. Islet cell and thyroid antibody prevalence in patients with hepatitis C virus infection: effect of treatment with interferon.
Piquer S; Hernández C; Enriquez J; Ross A; Esteban JI; Genescà J; Bonifacio E; Puig-Domingo M; Simó R
J Lab Clin Med; 2001 Jan; 137(1):38-42. PubMed ID: 11150022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
